Product Overview
Generic name: Ji Gu Cao Capsule
Chinese Pinyin: Jigucaojiaonang
Product name: Yulin
Ingredients: The main ingredients of this product are Panax notoginseng, artificial bezoar, pig bile, oregano, chicken bone grass, white peony, jujube, gardenia, cylindrica, and wolfberry.
Properties: This product is a capsule. The content is brown powder; bitter taste.
Functions and indications: Soothes the liver and promotes gallbladder, clears heat and detoxifies. For acute and chronic hepatitis, hepatitis, cholecystitis, and those with liver and gallbladder damp-heat.
Specification: 0.5g*36 capsules/bottle
Usage and dosage: Orally, 4 capsules at a time, 3 times a day.
Adverse reactions: not yet clear
Contraindications: Prohibited by pregnant women.
Note: 1 Avoid smoking, alcohol and spicy food. 2 It is not advisable to take nourishing Chinese medicines during the medication. 3 People with severe chronic diseases such as high blood pressure, heart disease, diabetes, liver disease, kidney disease should take it under the guidance of a physician. 4 If the symptoms are not relieved after taking the medicine for 3 days, you should go to the hospital for treatment. 5 Children, the elderly and the infirm should take it under the guidance of a doctor. 6 Those who are allergic to this product should not use it with caution. 7 It is forbidden to take the medicine when its properties change. 8 Children must be used under adult supervision. 9 Please keep this medicine out of reach of children. 10 If you are taking other medicines, please consult your physician or pharmacist before using this product.
Pharmacology and Toxicology: Pharmacodynamic studies have shown that Jigucao Capsule has a significant effect on lowering transaminase after acute liver damage caused by D-aminohemiglucosamine in mice; it has a significant effect on reducing enzymes in mice C caused by carbon tetrachloride. Amino acid aminotransferase (ALT) elevation has a significant inhibitory effect, and aspartate aminotransferase (AST) elevation also shows a certain inhibitory effect; it has a significant protective effect on rat experimental liver cirrhosis models ; It has inhibitory effect on hepatitis B HbsAg and HbeAg (ELISA method); it has obvious enhancement effect on the immune function of mice; it has obvious anti-inflammatory and analgesic effects on acute inflammation and chronic inflammation in mice; it can significantly increase The secretion of rat bile. 1. Acute toxicity: Gavage to mice, the maximum tolerated dose of this product is 220.8g/kg (equivalent to crude drugs), which is equivalent to 381 times the clinical dose (28.98g/50kg/day). 2. Long-term toxicity: The rats were given continuous intragastric administration at 10 times and 50 times the clinical dose for 24 weeks. The results showed that the weight of the animals in the administration group increased slowly, and the high-dose group was more obvious. See abnormal changes in other general conditions of animals; after the end of administration, the total serum protein and total bilirubin in the high-dose group increased, and blood sugar decreased, but these changes were reversible. Histological examination showed that the high-dose group had mild kidney disease. The physiology has changed, but the results suggest that it is also reversible. There were no significant changes in hematology and blood biochemical indexes and histology in the low-dose group.
Medication for pregnant women and lactating women: Prohibited for pregnant women.
Children's medication: Children should be taken under the guidance of a doctor.
Medication for elderly patients: The elderly should be taken under the guidance of a physician.
Storage: shading, sealed and stored. (Not exceeding 20℃)
Packing: 0.5g*36 capsules/bottle
Validity period: 36 months
Approval number: National Medicine Standard Z45021655
Company Name: Guangxi Yulin Pharmaceutical Group Co., Ltd.
